UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
A straightforward framework to help newcomers pick their initial cryptocurrency with confidence.
25,127 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Oil prices rose and energy stocks jumped after the tensions since iran began. This guide breaks down whether it’s sti...
SentinelOne stock has bounced off a rough patch, but is it a buy after stock declines? This guide lays out how to eva...
Visa and Mastercard posted stronger-than-expected Q1 results as cross-border spending rebounds. The key question for ...
A short clip of a man in Brampton clearing snow with a lawnmower exploded into a national conversation about who belo...
For the 16th straight week, home listing prices fall across many markets as higher borrowing costs and rising invento...
As markets swing in early 2026, more households seek trustworthy guidance. A new platform promises fast access to fid...
A real estate liquidity squeeze is unfolding as investors pull billions from property funds. Could this be the first ...
A high-profile moment in Brazil becomes a money lesson for everyday readers. This article uses oliver tree’s first br...
Markets react to kevin warsh’s first meeting as Fed chair, with stocks rising, bond yields fluctuating and traders we...
Sofi stocks have shown impressive momentum, but two big risks loom: a concentrated Galileo platform revenue stream an...
Ripple's XRPL launches an AI Starter Kit to enable autonomous AI agents to transact with XRP and RLUSD, aiming to lea...